Tegaserod

Chemical formula: C₁₆H₂₃N₅O  Molecular mass: 301.394 g/mol  PubChem compound: 5362436

Active ingredient description

Tegaserod is an agonist of serotonin type-4 (5-HT4) receptors that stimulates the peristaltic reflex and intestinal secretion, inhibits visceral sensitivity, enhances basal motor activity, and normalizes impaired motility throughout the gastrointestinal tract.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A06AX06 A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AX Other laxatives
Discover more medicines within A06AX06

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
ZELNORM Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 145158-71-0
DrugBank Drug: DB01079
KEGG Drug: D06056
PubChem Compound: 5362436
RxNorm Ingredient: 139778
SNOMED-CT Concept: 417025001
Tegaserod (substance)
UNII Identifier: 458VC51857
TEGASEROD

Medicines

Tegaserod is an active ingredient of these brands:

United States (US)

Brazil (BR)

Estonia (EE)

Mexico (MX)

South Africa (ZA)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.